Efficacy and activity of levetiracetam on Multiple Sclerosis cerebellar symptoms: a multicenters double blind, randomized, placebo-controlled, cross over study - ND Efficacy and activity of levetiracetam on Multiple Sclerosis cerebellar symptoms: a multicenters dou ...
Efficacy and activity of levetiracetam on Multiple Sclerosis cerebellar symptoms: a multicenters double blind, randomized, placebo-controlled, cross over study - ND Efficacy and activity of levetiracetam on Multiple Sclerosis cerebellar symptoms: a multicenters dou ...
Patients with an established and stable Multiple Sclerosis (according to Poser criteria). MedDRA version: 9.1;Level: LLT;Classification code 10028245;Term: Multiple sclerosis Patients with an established and stable Multiple Sclerosis (according to Poser criteria). MedDRA ver ...
Trade Name: KEPPRA INN or Proposed INN: Levetiracetam
Double-blind, randomised, placebo-controlled trial of levetiracetam for central neuropathic pain in patients with multiple sclerosis - levetiracetam for central neuropathic pain in patients with multiple sclerosis Double-blind, randomised, placebo-controlled trial of levetiracetam for central neuropathic pain in ...
Double-blind, randomised, placebo-controlled trial of levetiracetam for central neuropathic pain in patients with multiple sclerosis - levetiracetam for central neuropathic pain in patients with multiple sclerosis Double-blind, randomised, placebo-controlled trial of levetiracetam for central neuropathic pain in ...
: The Role of Keppra in the Treatment of Tremor in Multiple Sclerosis
: The Role of Keppra in the Treatment of Tremor in Multiple Sclerosis
Multiple Sclerosis
Trade Name: Keppra 250mg INN or Proposed INN: Levetiracetam Trade Name: Keppra 500mg Product Name: Keppra ® Trade Name: Keppra250mg INN or Proposed INN: Levetiracetam Trade Name: Keppra500mg Product Name: Keppra ...
Newcastle-upon-Tyne Hospitals NHS Trust
NULL
Not Recruiting
Female: yes Male: yes
20
Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (Phase 3): no Therapeutic use (Phase 4): yes Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...